Applying machine learning techniques for ADME-Tox prediction: a review
暂无分享,去创建一个
Vinícius Gonçalves Maltarollo | Jadson Castro Gertrudes | Patrícia Rufino Oliveira | Kathia Maria Honorio | P. R. Oliveira | J. C. Gertrudes | V. Maltarollo | K. M. Honório
[1] Sunil S. Jambhekar. Physicochemical and Biopharmaceutical Properties of Drug Substances and Pharmacokinetics , 2009 .
[2] Bruno Sarmento,et al. Models to predict intestinal absorption of therapeutic peptides and proteins. , 2012, Current drug metabolism.
[3] Jie Shen,et al. admetSAR: A Comprehensive Source and Free Tool for Assessment of Chemical ADMET Properties , 2012, J. Chem. Inf. Model..
[4] Adriano D Andricopulo,et al. Consensus hologram QSAR modeling for the prediction of human intestinal absorption. , 2012, Bioorganic & medicinal chemistry letters.
[5] Xiaoling Li,et al. In silico model of drug permeability across sublingual mucosa. , 2013, Archives of oral biology.
[6] Chang-Ying Ma,et al. In silico prediction of mitochondrial toxicity by using GA-CG-SVM approach. , 2009, Toxicology in vitro : an international journal published in association with BIBRA.
[7] Philippe Vayer,et al. Toward in silico structure-based ADMET prediction in drug discovery. , 2012, Drug discovery today.
[8] Alexander Tropsha,et al. k Nearest Neighbors QSAR Modeling as a Variational Problem: Theory and Applications , 2005, J. Chem. Inf. Model..
[9] R. Cramer. Partial Least Squares (PLS): Its strengths and limitations , 1993 .
[10] Ingo Muegge,et al. DemQSAR: predicting human volume of distribution and clearance of drugs , 2011, J. Comput. Aided Mol. Des..
[11] Taravat Ghafourian,et al. QSAR models for the prediction of plasma protein binding. , 2013, BioImpacts : BI.
[12] Andreas Bender,et al. Similarity Searching of Chemical Databases Using Atom Environment Descriptors (MOLPRINT 2D): Evaluation of Performance , 2004, J. Chem. Inf. Model..
[13] Veerabahu Shanmugasundaram,et al. Estimation of Aqueous Solubility of Organic Compounds with QSPR Approach , 2002, Pharmaceutical Research.
[14] R. Shinde,et al. Insights into the permeability of drugs and drug-likemolecules from MI-QSAR and HQSAR studies , 2012, Journal of Molecular Modeling.
[15] Thomas Sander,et al. OSIRIS, an Entirely in-House Developed Drug Discovery Informatics System , 2009, J. Chem. Inf. Model..
[16] Igor V. Tetko,et al. Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices , 2001, J. Chem. Inf. Comput. Sci..
[17] Cheng Chen,et al. MI-QSAR models for prediction of corneal permeability of organic compounds , 2006, Acta Pharmacologica Sinica.
[18] Hui Zhang,et al. An integrated scheme for feature selection and parameter setting in the support vector machine modeling and its application to the prediction of pharmacokinetic properties of drugs , 2009, Artif. Intell. Medicine.
[19] Jarmo Huuskonen,et al. Estimation of Aqueous Solubility for a Diverse Set of Organic Compounds Based on Molecular Topology , 2000, J. Chem. Inf. Comput. Sci..
[20] R. Enriz,et al. The legacy of the past, the reality of the present and the hopes of the future , 2005 .
[21] C. Selassie,et al. History of Quantitative Structure–Activity Relationships , 2010 .
[22] Johann Gasteiger,et al. Prediction of Aqueous Solubility of Organic Compounds Based on a 3D Structure Representation , 2003, J. Chem. Inf. Comput. Sci..
[23] Shigeo Abe DrEng. Pattern Classification , 2001, Springer London.
[24] Stephan Schmidt,et al. Significance of protein binding in pharmacokinetics and pharmacodynamics. , 2010, Journal of pharmaceutical sciences.
[25] Adriano D. Andricopulo,et al. A fragment-based approach for the in silico prediction of blood-brain barrier permeation , 2012 .
[26] Lijuan Chen,et al. Results of molecular docking as descriptors to predict human serum albumin binding affinity. , 2012, Journal of molecular graphics & modelling.
[27] Heng Tao Shen,et al. Principal Component Analysis , 2009, Encyclopedia of Biometrics.
[28] A. Tropsha,et al. kappa Nearest neighbors QSAR modeling as a variational problem: theory and applications. , 2005, Journal of chemical information and modeling.
[29] John C Lindon,et al. Development of quantitative structure-metabolism (QSMR) relationships for substituted anilines based on computational chemistry , 2013, Xenobiotica; the fate of foreign compounds in biological systems.
[30] Björn Krüger,et al. The holistic integration of virtual screening in drug discovery. , 2013, Drug discovery today.
[31] Emilio Xavier Esposito,et al. Membrane‐Interaction Quantitative Structure—Activity Relationship (MI‐QSAR) Analyses of Skin Penetration Enhancers. , 2008 .
[32] Nello Cristianini,et al. An Introduction to Support Vector Machines and Other Kernel-based Learning Methods , 2000 .
[33] Wei Li,et al. Three-class classification models of logS and logP derived by using GA–CG–SVM approach , 2009, Molecular Diversity.
[34] Tingjun Hou,et al. ADME Evaluation in Drug Discovery. 4. Prediction of Aqueous Solubility Based on Atom Contribution Approach , 2004, J. Chem. Inf. Model..
[35] D. Sprous,et al. QSAR in the pharmaceutical research setting: QSAR models for broad, large problems. , 2010, Current topics in medicinal chemistry.
[36] Simon Haykin,et al. Neural Networks and Learning Machines , 2010 .
[37] Yuquan Wei,et al. Prediction models of human plasma protein binding rate and oral bioavailability derived by using GA-CG-SVM method. , 2008, Journal of pharmaceutical and biomedical analysis.
[38] Scott Boyer,et al. Reaction Site Mapping of Xenobiotic Biotransformations , 2007, J. Chem. Inf. Model..
[39] Tomasz Arodz,et al. Computational methods in developing quantitative structure-activity relationships (QSAR): a review. , 2006, Combinatorial chemistry & high throughput screening.
[40] R. Schoenwald,et al. Pharmacokinetics in Drug Discovery and Development , 2002 .
[41] I. Khanna,et al. Drug discovery in pharmaceutical industry: productivity challenges and trends. , 2012, Drug discovery today.
[42] J C Gertrudes,et al. Machine learning techniques and drug design. , 2012, Current medicinal chemistry.
[43] R D Benz,et al. (Q)SAR Modeling and Safety Assessment in Regulatory Review , 2012, Clinical pharmacology and therapeutics.
[44] O. Engkvist,et al. Beyond size, ionization state, and lipophilicity: influence of molecular topology on absorption, distribution, metabolism, excretion, and toxicity for druglike compounds. , 2012, Journal of medicinal chemistry.
[45] Tatiana Nikolskaya,et al. Prediction of Organ Toxicity Endpoints by QSAR Modeling Based on Precise Chemical‐Histopathology Annotations , 2012, Chemical biology & drug design.
[46] John Ferguson,et al. The Use of Chemical Potentials as Indices of Toxicity , 1939 .
[47] Andreas Bender,et al. The challenges involved in modeling toxicity data in silico: a review. , 2012, Current pharmaceutical design.
[48] Darko Butina,et al. Modeling Aqueous Solubility , 2003, J. Chem. Inf. Comput. Sci..
[49] A. Beresford,et al. The emerging importance of predictive ADME simulation in drug discovery. , 2002, Drug discovery today.
[50] Tingjun Hou,et al. ADME evaluation in drug discovery , 2002, Journal of molecular modeling.
[51] I. Cockburn,et al. The changing structure of the pharmaceutical industry. , 2004, Health affairs.
[52] T. Baillie,et al. Metabolism and toxicity of drugs. Two decades of progress in industrial drug metabolism. , 2008, Chemical research in toxicology.
[53] Sheng Tian,et al. ADME evaluation in drug discovery. 9. Prediction of oral bioavailability in humans based on molecular properties and structural fingerprints. , 2011, Molecular pharmaceutics.
[54] Rebecca Denton,et al. A rapid computational filter for predicting the rate of human renal clearance. , 2010, Journal of molecular graphics & modelling.
[55] Vladimir N. Vapnik,et al. The Nature of Statistical Learning Theory , 2000, Statistics for Engineering and Information Science.
[56] Hui Zhang,et al. Support vector machine and pharmacophore-based prediction models of multidrug-resistance protein 2 (MRP2) inhibitors. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[57] K. Luthman,et al. Caco-2 monolayers in experimental and theoretical predictions of drug transport. , 2001, Advanced drug delivery reviews.
[58] Dong-Sheng Cao,et al. Automatic feature subset selection for decision tree-based ensemble methods in the prediction of bioactivity , 2010 .
[59] Adriano D Andricopulo,et al. Pharmacokinetic properties and in silico ADME modeling in drug discovery. , 2013, Medicinal chemistry (Shariqah (United Arab Emirates)).
[60] Jianzhong Liu,et al. Prediction and mechanistic interpretation of human oral drug absorption using MI-QSAR analysis. , 2007, Molecular pharmaceutics.
[61] Hua Yu,et al. A Novel Chemometric Method for the Prediction of Human Oral Bioavailability , 2012, International journal of molecular sciences.
[62] Jerzy Leszczynski,et al. CORAL: QSPR model of water solubility based on local and global SMILES attributes. , 2013, Chemosphere.
[63] H. Abdi,et al. Principal component analysis , 2010 .
[64] Marc Decramer,et al. Who can pay for innovative medicines? , 2013, European Respiratory Journal.
[65] Hao Sun,et al. Structure‐based Drug Metabolism Predictions for Drug Design , 2010, Chemical biology & drug design.
[66] A. J. Hopfinger,et al. Predicting Blood–Brain Barrier Partitioning of Organic Molecules Using Membrane–Interaction QSAR Analysis , 2002, Pharmaceutical Research.
[67] Sean B. Holden,et al. Support Vector Machines for ADME Property Classification , 2003 .
[68] Adriano D. Andricopulo,et al. PK/DB: database for pharmacokinetic properties and predictive in silico ADME models , 2008, Bioinform..
[69] Eric R. Ziegel,et al. The Elements of Statistical Learning , 2003, Technometrics.
[70] Adriano D Andricopulo,et al. Hologram QSAR model for the prediction of human oral bioavailability. , 2007, Bioorganic & medicinal chemistry.
[71] Berith F. Jensen,et al. In silico prediction of cytochrome P450 2D6 and 3A4 inhibition using Gaussian kernel weighted k-nearest neighbor and extended connectivity fingerprints, including structural fragment analysis of inhibitors versus noninhibitors. , 2007, Journal of medicinal chemistry.
[72] Andreas Zell,et al. Kernel Functions for Attributed Molecular Graphs – A New Similarity‐Based Approach to ADME Prediction in Classification and Regression , 2006 .
[73] T Scior,et al. How to recognize and workaround pitfalls in QSAR studies: a critical review. , 2009, Current medicinal chemistry.
[74] M Paul Gleeson,et al. Plasma protein binding affinity and its relationship to molecular structure: an in-silico analysis. , 2007, Journal of medicinal chemistry.
[75] K. Luthman,et al. Correlation of drug absorption with molecular surface properties. , 1996, Journal of pharmaceutical sciences.
[76] David G. Stork,et al. Pattern Classification , 1973 .
[77] Jie Yang,et al. Predicting MDCK cell permeation coefficients of organic molecules using membrane-interaction QSAR analysis , 2005, Acta Pharmacologica Sinica.
[78] Katherine Tsaioun,et al. ADMET for Medicinal Chemists: A Practical Guide , 2011 .
[79] Aki T Heikkinen,et al. Modelling of drug disposition kinetics in in vitro intestinal absorption cell models. , 2010, Basic & clinical pharmacology & toxicology.
[80] Olivier Sperandio,et al. In Silico ADME/Tox Predictions , 2010 .
[81] Antanas Verikas,et al. Mining data with random forests: A survey and results of new tests , 2011, Pattern Recognit..
[82] John S. Delaney,et al. ESOL: Estimating Aqueous Solubility Directly from Molecular Structure , 2004, J. Chem. Inf. Model..
[83] Heekuck Oh,et al. Neural Networks for Pattern Recognition , 1993, Adv. Comput..
[84] Ian H. Witten,et al. Data mining: practical machine learning tools and techniques, 3rd Edition , 1999 .
[85] Ulf Norinder,et al. In silico categorization of in vivo intrinsic clearance using machine learning. , 2013, Molecular pharmaceutics.
[86] Carlos A. Montanari,et al. In Silico Prediction of Human Plasma Protein Binding Using Hologram QSAR , 2007 .
[87] Leo Breiman,et al. Random Forests , 2001, Machine Learning.